Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non‐small‐cell lung cancer patients

error_outline

You have to enable JavaScript in your browser's settings in order to use the eReader.

Or try downloading the content offline